NR4A1 inhibits TGF-β signaling, which can suppress experimental lung and liver fibrosis [25], but whether NR4A1 inhibits HSC activation and liver fibrosis through the EMT is unknown. Here, TGFB1 is linked to Hepatic fibrosis.